Soon it will be possible to determine the gender of the unborn child already at the earliest stages of pregnancy-from 5-6 weeks. Scientists from the Women's Medical Hospital in Boston have developed an innovative method, which allows the mother’s gender to determine the gender of the baby at such an early period by analyzing. This test can be used with the same convenience as the usual pregnancy pharmacy tests.

The new method is based on the analysis of the fetal DNA, which appears in the blood of the mother since the 6th week of pregnancy. Scientists have found that on the basis of the ratio of chromosomes X and Y, it is possible to determine the gender of the baby with high accuracy. This discovery promises to become an important step in the field of medical diagnostics, as it avoids more invasive methods such as amniocentesis or choriona villi biopsy, which are used to obtain information about the health of the fetus.

Blood test to determine the sex of the child is distinguished by its safety and ethics, since it does not require intervention in the body of the mother or fetus. Thus, this method significantly reduces the risks associated with traditional procedures that can affect the condition of a pregnant woman and her unborn child.

At the moment, testing of the method takes place in a large sample - 6.5 thousand women, which confirms its reliability. Already now the results show high accuracy: at the 7th week of pregnancy, the accuracy of the analysis is 95%, and in the 20th week reaches 99%. This indicates a high level of reliability, which can be expected from the dough with its widespread use.

Soon such a test may become available for mass use, and every woman expecting a child will be able to find out the gender of the baby by blood analysis even in the earliest stages. This will open new horizons in the field of early diagnosis and generally make the process of pregnancy for women more comfortable and predictable.

In addition, the use of such a test can greatly facilitate medical monitoring of the development of pregnancy, allowing doctors to respond in a timely manner to possible risks and diseases. It will also help improve the quality of prenatal diagnosis and reduce the level of complications associated with insufficient informality about the condition of the fetus.

. Com. UA.